However, some individuals may experience mild digestive discomfort, nausea, stomach upset, or headache when beginning supplementation
Swiss Re said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual rate of death by up to 6.4 per cent in the United States by 2045
Fecal BA is a cost-effective, accurate biomarker, and it is associated with obvious bowel dysfunction in IBS-D and IBS-C patients
M.GiglioR
There are several benefits, including: Enhanced fat metabolism, particularly targeting stubborn areas
An important early example investigated the effect of both knockout and transgenic uricase in mice receiving intracerebral 6-hydroxydopamine administration, which leads to dopaminergic neurodegeneration 33